RN7SL25P

Across TCGA pan-cancer cohorts, RN7SL25P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL25P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RN7SL25P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL25P is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.

THCA, KIRC, and BRCA are the cancer types where RN7SL25P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL25P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.156	<.001	8	view →
KIRC	All	All	−0.126	<.001	7	view →
BRCA	All	All	+0.068	.035	4	view →
LIHC	All	All	+0.083	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL25P–THCA

Open the THCA breakdown →